MedPath

TESTOSTERONE ENANTHATE INJECTION, USP

TESTOSTERONE ENANTHATE INJECTION, USP

Approved
DIN Number

02536315

Drug Class

Human

Market Date

Jan 30, 2024

Company
HC

hikma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02536315
AIG Number0106403001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification68:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TESTOSTERONE ENANTHATEActive
Strength: 200 MG / ML
Monograph: TESTOSTERONE ENANTHATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.